GSK, Innoviva seek EMA approval for Trelegy Ellipta to treat asthma in adults

GSK, Innoviva seek EMA approval for Trelegy Ellipta to treat asthma in adults

Submitted by admin on February 28, 2020 - 10:30am
Source: 
Pharmaceutical Business Review
News Tags: 
GSK
Innoviva
EMA
Europe
asthma
Trelegy Elipta
Headline: 
GSK, Innoviva seek EMA approval for Trelegy Ellipta to treat asthma in adults
snippet: 


British drugmaker GlaxoSmithKline (GSK) and Innoviva are seeking approval from the European Medicines Agency (EMA) for an additional indication of Trelegy Ellipta to treat adult patients with asthma.

Do Not Allow Advertisers to Use My Personal information